# IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention

> **NCT07318363** · PHASE3 · NOT_YET_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 2100 (estimated)

## Conditions studied

- Communication
- Informed Decision-making

## Interventions

- **OTHER:** IGNITE-TX program
- **OTHER:** Genetic Counseling and Testing

## Key facts

- **NCT ID:** NCT07318363
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2030-04-01
- **Final completion:** 2032-04-01
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07318363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07318363, "IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07318363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*